Teleflex Inc
NYSE:TFX

Watchlist Manager
Teleflex Inc Logo
Teleflex Inc
NYSE:TFX
Watchlist
Price: 135.52 USD 0.33% Market Closed
Market Cap: $6B

Teleflex Inc
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Teleflex Inc
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Teleflex Inc
NYSE:TFX
Net Income (Common)
-$905.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Net Income (Common)
$3.6B
CAGR 3-Years
62%
CAGR 5-Years
78%
CAGR 10-Years
N/A
Edwards Lifesciences Corp
NYSE:EW
Net Income (Common)
$1.1B
CAGR 3-Years
-10%
CAGR 5-Years
5%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Net Income (Common)
$3.2B
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Net Income (Common)
$6.3B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
10%
Intuitive Surgical Inc
NASDAQ:ISRG
Net Income (Common)
$2.9B
CAGR 3-Years
29%
CAGR 5-Years
22%
CAGR 10-Years
17%
No Stocks Found

Teleflex Inc
Glance View

In the world of medical technology, Teleflex Inc. emerges as a nuanced, multifaceted player, crafting a narrative not just of survival, but of steady growth through innovation and strategic vision. Founded in the allure of post-war optimism in 1943, Teleflex began its journey in the aerospace and marine industries. However, recognizing the steadily aging global population and increasing healthcare demands, the company pivoted towards the medical sector, a decision that has since defined its contemporary identity. Teleflex now thrives as a diversified global provider of medical technologies designed to improve health and the quality of people's lives. It specializes in critical care and surgical solutions, focusing its efforts on areas like vascular access, anesthesia, respiratory care, and urology, among others. Teleflex Inc. crafts its financial landscape through a robust combination of product innovation, strategic acquisitions, and a strong global footprint. Their revenue streams are primarily derived from selling medical devices and equipment to healthcare providers worldwide. A significant competitive edge lies in its ability to consistently introduce new products that address unmet clinical needs while enhancing patient safety and outcomes. This focus is evident in their Research and Development initiatives, which are integral to maintaining their market position. Moreover, by acquiring companies with complementary technologies and market reach, Teleflex continually broadens its portfolio, navigating the complex and evolving healthcare landscape with finesse and agility. Through these strategic maneuvers, the company ensures a steady flow of revenue that aligns with global healthcare trends and demands.

TFX Intrinsic Value
126.55 USD
Overvaluation 7%
Intrinsic Value
Price $135.52

See Also

What is Teleflex Inc's Net Income (Common)?
Net Income (Common)
-905.6m USD

Based on the financial report for Dec 31, 2025, Teleflex Inc's Net Income (Common) amounts to -905.6m USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett